Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin effects on visual and sleep anomalies in Retinitis Pigmentosa
2012-002436-82Phase 3Active
- Sponsor
- Isabel Pinilla Lozano
- Start
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in retinitis pigmentosa (RP) and sleep disorder, sponsored by Isabel Pinilla Lozano. Primary endpoints: Sleep quality (PSQI), Daytime sleepiness (ESS) and 1 more. Started Oct 2012; status: active.
02
Drugs
melatonin
03
Conditions
retinitis pigmentosa (RP)sleep disorder
Beyond the preview
Go deeper on 2012-002436-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002436-82.